In pancreatic cancer, high GPER1 expression has been associated with improved survival [27], and GPER1 activation leads to peritumoral mesenchymal remodelling in PDAC, reducing fibrous tissue proliferation, inflammation and immunosuppression [28]. The gene discussed is GPER1; the disease is familial pancreatic carcinoma.